Search

Search Constraints

You searched for: Author/Creator Smith, Philip J

Search Results

2. Adalimumab and Infliximab Impair SARS-CoV-2 Antibody Responses: Results from a Therapeutic Drug Monitoring Study in 11 422 Biologic-Treated Patients. (2nd September 2021)

3. Adaptations to the British Society of Gastroenterology guidelines on the management of acute severe UC in the context of the COVID-19 pandemic: a RAND appropriateness panel. Issue 10 (8th June 2020)

5. Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab. Issue 5 (22nd March 2021)

6. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. (27th September 2019)

7. British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic. Issue 6 (17th April 2020)

9. Comparative effectiveness of ustekinumab or vedolizumab after one year in 130 patients with anti‐TNF‐refractory Crohn's disease. Issue 8 (10th September 2020)